The Role of Fibrinolysis in the Therapy of Peripheral Vascular Disease
- 1 July 1984
- journal article
- research article
- Published by SAGE Publications in Angiology
- Vol. 35 (7) , 436-442
- https://doi.org/10.1177/000331978403500706
Abstract
In vivo thrombolytic studies in stumptailed monkeys indicated that pentoxifylline potentiates thrombolysis induced by urokinase activated human plasmin. Pentoxifylline as well as prostaglandin E1 released plasminogen activators and activated the fibrinolysin system. From this point of view pentoxifylline and prostaglandin E1 synergized with each other. Pentoxifylline potentiated the thrombolytic effect of prostaglandin E1 in vivo.This publication has 15 references indexed in Scilit:
- Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patientsAmerican Heart Journal, 1982
- Inhibitors of fibrinolysis in diabetic children, mothers, and their newbornAmerican Journal of Hematology, 1979
- The fibrinolysin system and its relationship to disease in the newbornJournal of Pediatric Hematology/Oncology, 1979
- The effect of oxpentifylline (Trental') on fibrinolytic activity and plasma fibrinogen levelsCurrent Medical Research and Opinion, 1977
- Statistical Evaluation of Polygraphic Investigations of PentoxifyllineJournal of International Medical Research, 1976
- Idiopathic gangrene in African children.BMJ, 1967
- Clinical pharmacology of various types of fibrinolytic enzyme preparationsThe American Journal of Cardiology, 1960
- Study on the Effect of Streptokinase-Activated Plasmin (Fibrinolysin) on Clots in Various Stages of Organization12Journal of Clinical Investigation, 1958
- CLINICAL AND EXPERIMENTAL STUDIES ON FIBRINOLYTIC ENZYMESAnnals of the New York Academy of Sciences, 1957
- Quantitative Method for the In Vivo Testing of Fibrinolytic Agents: Effect of Intravenous Trypsin on Radioactive Thrombi and EmboliCirculation Research, 1956